Combination Antioxidant Effect of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury in Rats

  • سال انتشار: 1392
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 16، شماره: 12
  • کد COI اختصاصی: JR_IJBMS-16-12_001
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 239
دانلود فایل این مقاله

نویسندگان

Nasser Ahmadiasl

Drug Applied Research Center, Tabriz University of Medical Sciences, Medical Faculty, Tabriz, Iran

Shokofeh Banaei

Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran

Alireza Alihemmati

Department of Histology & Embryology, Tabriz University of Medical Sciences, Medical Faculty, Tabriz, Iran

چکیده

  Objective(s): Renal ischemia reperfusion (IR) contributes to the development of acute renal failure (ARF). Oxygen free radicals are considered to be principal components involved in the pathophysiological tissue alterations observed during renal IR. The purpose of this study was to investigate the effect of co-administration of melatonin (MEL) and erythropoietin (EPO), potent antioxidant and anti-inflammatory agents, on IR-induced renal injury in rats.   Materials and Methods: Wistar albino rats were unilaterally nephrectomized and subjected to ۴۵ min of renal pedicle occlusion followed by ۲۴ hr reperfusion. MEL (۱۰ mg/kg, IP) and EPO (۵۰۰۰ U/kg, IP) were administered prior to ischemia. After ۲۴ hr reperfusion, following decapitation, renal samples were taken for the determination of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) levels and histological evaluation. The level of urea was measured in serum samples. Results: Ischemia reperfusion significantly increased urea, and MDA levels, and decreased CAT and SOD activities. Histopathological findings of the IR group confirmed that there was renal impairment in the tubular epithelium. Treatment with EPO and MEL markedly decreased urea level and increased SOD and GPx activities. Conclusion: Treatment with EPO and MEL had a beneficial effect on renal IR injury. These results may show that the co-administration of MEL and EPO cannot exert more beneficial effects than either agent alone.

کلیدواژه ها

Antioxidant Erythropoietin Ischemia Reperfusion Injury Kidney Lipid Peroxidation Melatonin

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.